Indrayani Biotech Ltd — Board Meeting, 17-08-2026: Board Meeting
17-08-2026 | 04:56 pm
17-08-2026 | 04:56 pm
IBL Indrayani Biotech's Board approved Q4 & FY26 audited financial results. Auditors issued a Qualified Opinion due to unconfirmed balances (loans, trade receivables) & subsidiaries not complying with IND AS. This signals significant financial reporting concerns for investors.
No comments yet. Be the first to comment!
